Bal Pharma Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
158.20 Cr.
|
P/BV
|
2.48
|
Book Value (Rs.)
|
40.43
|
52 Week High/Low (Rs.)
|
132/70
|
FV/ML
|
10/1
|
P/E(X)
|
61.52
|
Bookclosure
|
25/09/2023
|
EPS (Rs.)
|
1.63
|
Div Yield (%)
|
1.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
No. of Equity Shares (in Lacs) | 156.90 | 148.24 | 148.24 | 141.72 | 141.72 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 15.69 | 14.82 | 14.82 | 14.17 | 14.17 |
Total Share Capital | 15.69 | 14.82 | 14.82 | 14.17 | 14.17 |
| | | | | |
Reserves and Surplus | 48.10 | 42.87 | 37.82 | 38.25 | 52.47 |
Total Reserves and Surplus | 48.10 | 42.87 | 37.82 | 38.25 | 52.47 |
Money Received Against Share Warrants | 0.00 | 0.94 | 0.94 | 0.00 | 0.00 |
Total Shareholders Funds | 63.79 | 58.63 | 53.58 | 52.43 | 66.64 |
Minority Interest | -0.09 | -0.13 | -0.23 | -7.09 | -6.42 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 30.52 | 27.01 | 23.93 | 23.15 | 28.76 |
Deferred Tax Liabilities [Net] | 2.87 | 0.60 | 2.63 | 3.58 | 4.18 |
Other Long Term Liabilities | 1.68 | 4.08 | 3.56 | 3.21 | 2.20 |
Long Term Provisions | 5.07 | 4.69 | 4.07 | 3.62 | 2.71 |
Total Non-Current Liabilities | 40.14 | 36.40 | 34.19 | 33.56 | 37.85 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 100.48 | 70.75 | 80.82 | 89.63 | 87.08 |
Trade Payables | 78.92 | 65.56 | 47.17 | 38.67 | 47.34 |
Other Current Liabilities | 29.30 | 28.60 | 23.89 | 30.69 | 28.32 |
Short Term Provisions | 0.64 | 0.73 | 0.66 | 0.50 | 0.51 |
Total Current Liabilities | 209.33 | 165.64 | 152.53 | 159.49 | 163.24 |
| | | | | |
Total Capital And Liabilities | 313.17 | 260.53 | 240.08 | 238.39 | 261.31 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 62.18 | 55.57 | 57.51 | 60.45 | 60.85 |
Intangible Assets | 10.46 | 7.99 | 7.25 | 6.43 | 5.71 |
Capital Work-In-Progress | 0.00 | 1.61 | 0.00 | 3.32 | 3.63 |
Fixed Assets | 72.64 | 65.18 | 64.76 | 70.20 | 70.19 |
Goodwill On Consolidation | 3.83 | 3.83 | 3.83 | 3.83 | 3.83 |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Deferred Tax Assets [Net] | 2.17 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Loans And Advances | 0.10 | 0.40 | 0.38 | 0.29 | 1.86 |
Other Non-Current Assets | 6.29 | 6.56 | 6.96 | 2.94 | 3.51 |
Total Non-Current Assets | 85.02 | 75.96 | 75.93 | 77.26 | 79.40 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Inventories | 98.01 | 74.40 | 60.39 | 67.71 | 69.75 |
Trade Receivables | 93.98 | 75.31 | 67.20 | 49.60 | 64.69 |
Cash And Cash Equivalents | 7.61 | 5.39 | 3.85 | 3.13 | 4.32 |
Short Term Loans And Advances | 0.96 | 2.37 | 2.06 | 2.21 | 2.16 |
OtherCurrentAssets | 27.60 | 27.10 | 30.65 | 38.48 | 40.98 |
Total Current Assets | 228.16 | 184.57 | 164.15 | 161.14 | 181.91 |
| | | | | |
Total Assets | 313.17 | 260.53 | 240.08 | 238.39 | 261.31 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 0.00 | 0.00 | 4.34 | 12.99 | 20.37 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 |
Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |